Business Context and Reporting Period
This Form 6-K filing by Woori Financial Group Inc. covers the month of August 2024. The report details a strategic corporate action approved by the Board of Directors on August 28, 2024, to acquire a controlling stake in Tongyang Life Insurance Co., Ltd. The acquisition aims to strengthen the group's competitiveness through active participation in the management of the target company.
Key Financial Metrics and Transaction Details
The transaction involves the acquisition of 121,565,627 registered common shares of Tongyang Life Insurance, representing 75.34% of its total issued shares. The purchase price is set at KRW 1,283,976,152,374, to be paid in cash. This amount represents 3.84% of Woori Financial Group's total consolidated equity as of December 31, 2023 (KRW 33,397,489,875,071). The filing does not provide current revenue, profit, or cash flow metrics for Woori Financial Group itself, but includes historical financial data for Tongyang Life Insurance.
| Key Metric (Tongyang Life Insurance) | FY2023 (Millions KRW) | FY2022 (Millions KRW) | FY2021 (Millions KRW) |
|---|---|---|---|
| Total Assets | 32,869,437 | 37,420,243 | 37,103,345 |
| Total Liabilities | 29,965,457 | 35,510,653 | 34,059,409 |
| Total Equity | 2,903,980 | 1,909,590 | 3,043,936 |
| Revenue | 3,250,821 | 10,279,587 | 6,347,567 |
| Net Income | 270,645 | 74,044 | 275,619 |
Note: FY2023 revenue includes insurance and investment operating revenue; FY2022 and FY2021 figures represent operating revenue only. FY2023 data reflects the application of K-IFRS No. 1109 and No. 1117.
Material Changes and Outlook
The primary material change is the planned incorporation of Tongyang Life Insurance as a subsidiary. The scheduled acquisition date is pending regulatory approval and other conditions. The filing does not provide specific forward-looking guidance, management commentary on future earnings, or a detailed risk assessment beyond the standard regulatory approval contingency. No unusual items or contingencies were disclosed in this specific text other than the dependency on regulatory approval for the closing date.
Investor Verification Checklist
- Confirm the final regulatory approval status and the definitive closing date for the acquisition.
- Verify the impact of the K-IFRS accounting standard changes (No. 1109 and No. 1117) on Tongyang Life Insurance's FY2023 comparability.
- Assess the integration plan and expected synergies from acquiring a 75.34% stake in Tongyang Life Insurance.
- Review Woori Financial Group's liquidity position to ensure the KRW 1.28 trillion cash payment does not strain capital adequacy ratios.